For years, Roche has been increasing medicine production in the United States. That could pay off for the drug maker as ...

As the nearly 130-year-old pharmaceutical company consolidated its CRM systems, it cut down on vendor costs and paved the way ...

David Roche of Quantum Strategy says a weaker dollar will drive 10-year yields to 5.5%, which will threaten the dollar's ...

Swiss drugmaker Roche is petitioning the U.S. government in direct talks for import tariff exemptions, arguing the products ...

Roche said on Tuesday it would invest $50 billion in the United States over the next five years, creating more than 12,000 ...

Momentum investing revolves around the idea of following a stock's recent trend in either direction. In the 'long' context, investors will be essentially be "buying high, but hoping to sell even ...

Roche’s exposure to the tariffs is mostly limited to four medicines, three of which it already produces in the U.S., ...

The move will also create 12,000 new jobs across the United States, with 6,500 in construction and 1,000 at “new and expanded ...

The biotech company Roche is receiving support towards its efforts to advance cancer diagnosis and digital pathology ...

Swiss pharmaceuticals powerhouse Roche says it plans to invest $50 billion in the United States over the next five years and ...

Roche will invest $50 billion in American manufacturing over the next five years, including building a new facility somewhere ...

The Basel-based company said the investment would go toward high-tech research and development sites and new manufacturing ...